The U.S. Food and Drug Administration has authorized a second pill to battle the rising tide of omicron infections.
The authorization for Merck’s molnupiravir COVID-19 pill comes just one day after Pfizer’s Paxlovid approval.
Latest on COVID-19 in Maine
#BREAKING: U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections: https://t.co/ztLS9gAxHF
— CBS 13 News (@WGME) December 23, 2021
Latest Local Central Maine News